Cover Image
市場調查報告書

全球組織學·細胞學市場分析:檢驗 (細胞學:子宮頸癌,乳癌,其他,組織學),地區 (北美,歐洲,亞太地區),市場區隔預測

Histology and Cytology Market Analysis By Type of Examination (Cytology (Cervical Cancer, Breast Cancer, Others), Histology), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 515320
出版日期 內容資訊 英文 80 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球組織學·細胞學市場分析:檢驗 (細胞學:子宮頸癌,乳癌,其他,組織學),地區 (北美,歐洲,亞太地區),市場區隔預測 Histology and Cytology Market Analysis By Type of Examination (Cytology (Cervical Cancer, Breast Cancer, Others), Histology), By Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2014 - 2025
出版日期: 2017年05月15日 內容資訊: 英文 80 Pages
簡介

本報告提供全球組織學·細胞學市場相關調查,彙整市場概要和檢查別,地區預測和各趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與調查範圍

第2章 摘要整理

第3章 產業預測

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 推動市場的要素
    • 阻礙市場的要素
  • 優先的主要機會
  • 產業分析:波特分析
  • PESTEL分析
  • 競爭模式

第4章 檢查別預測

  • 市場佔有率
  • 細胞學
    • 子宮頸癌
    • 乳癌
    • 其他
  • 組織學

第5章 各地區預測與趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東非洲

第6章 競爭環境

  • 競爭環境
  • 策略架構

第7章 企業簡介

  • Becton Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Hologic, Inc.
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Sysmex Corporation
  • Trivitron Healthcare
  • Merck KGaA

圖表

目錄
Product Code: GVR-1-68038-917-3

The global histology and cytology market size is expected to reach USD 26.9 billion by 2025, according to a new report by Grand View Research, Inc. Globally, the increasing incidence of cancer and growing adoption of cytological tests due to its less invasive nature as compared to biopsy & higher reliability are likely to drive the market during the forecast period.

Furthermore, rising well-equipped clinical laboratories in developing countries and favorable reimbursement for cancer screening and laboratory tests are likely to positively affect the market growth. Advancements in the cytology and histology save the time for pathologists, hence this makes the service more cost-effective.

Cytology was the largest segment in the histology and cytology market in 2016 and is expected to maintain its dominance during the forecast period due to the recent entry of various tests for cytological testing and advantages over histology such as faster analysis and economical technique.

Cytology is further segmented into cervical, breast, and other cancers based on its application. Cervical cancer segment dominated in 2016 due to higher incidence and growing demand of test for the cervical cancer screening. Furthermore, breast cancer was considered as the second largest segment due to rising awareness about breast cancer screening in emerging countries.

Further key findings from the report suggest:

  • Rising incidence of cancer and growing investment by players are expected to propel growth at the fastest rate with a CAGR of 13.5% from 2017 to 2025
  • Cytology testing segment dominated in 2016 and is estimated to account for majority of the share by 2025.
  • Cytological testing for cervix is the largest contributing segment of the market. This can be attributed to high incidence and more adoption of the test for cervix screening.
  • The U.S. market was the largest in 2016 and is expected to maintain its dominance during forecast period due to higher awareness about screening and higher healthcare expenditure as compared to the developing countries.
  • In February 2014, Roche launched a new test for cervical cancer screening, Automated CINtec PLUS cytology test, which improves the detection of cervical precancer.
  • The industry in Asia Pacific is projected to witness substantial growth over the next decade owing to growing investment by several clinics in the region, growing healthcare expenditure, and increasing adoption of screening tests.
  • Some of the key players operating are Abbott Laboratories; Becton, Dickinson and Company; F. Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; and Trivitron Healthcare.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Scope & Assumptions
  • 1.3. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Histology and Cytology Industry Outlook

  • 3.1. Market segmentation
  • 3.2. Market size and growth prospects, 2014 - 2025
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Key Opportunities Prioritized
  • 3.5. Industry Analysis - Porter's
  • 3.6. PESTEL Analysis, 2015
  • 3.7. Histology and Cytology Competitive Scenario, 2016
    • 3.7.1. Competitive landscape/Heat map analysis: Market position analysis (based on product portfolio, regional presence and strategic initiatives)

Chapter 4. Histology and Cytology Market: Type of Examination Outlook

  • 4.1. Histology and Cytology Market Share by Test, 2016& 2025 (USD Million)
  • 4.2. Cytology
    • 4.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
    • 4.2.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
    • 4.2.3. Cervical Cancer
      • 4.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 4.2.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
    • 4.2.4. Breast Cancer
      • 4.2.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 4.2.4.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
    • 4.2.5. Other Cancers
      • 4.2.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 4.2.5.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)
  • 4.3. Histology
    • 4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
    • 4.3.2. Market estimates and forecast by region, 2014 - 2025 (USD Million)

Chapter 5. Histology and Cytology Market: Regional Outlook

  • 5.1. Histology and Cytology Market Share by Region, 2016 & 2025 (USD Million)
  • 5.2. North America
    • 5.2.1. Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.2.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.2.3. U.S.
      • 5.2.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.2.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.2.4. Canada
      • 5.2.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.2.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • 5.3. Europe
    • 5.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.3.3. Germany
      • 5.3.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.3.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.3.4. U.K.
      • 5.3.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.3.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.4.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.4.4. Japan
      • 5.4.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.4.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • 5.5. Central & South America
    • 5.5.1. Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.5.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.5.3. Brazil
      • 5.5.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.5.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.5.4. Mexico
      • 5.5.4.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.5.4.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • 5.6. Middle East & Africa
    • 5.6.1. Market estimates and forecast, 2014 - 2025 (USD Million)
    • 5.6.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
    • 5.6.3. South Africa
      • 5.6.3.1. Market estimates and forecast, 2014 - 2025 (USD Million)
      • 5.6.3.2. Market estimates and forecast by type of examination, 2014 - 2025 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Competitive Environment
  • 6.2. Strategy Framework

Chapter 7. Company Profiles

  • 7.1. Becton Dickinson and Company
    • 7.1.1. Company overview
    • 7.1.2. Financial performance
    • 7.1.3. Industries and services catered
    • 7.1.4. Product benchmarking
    • 7.1.5. Strategic initiatives
  • 7.2. F. Hoffmann-La Roche Ltd.
    • 7.2.1. Company overview
    • 7.2.2. Financial performance
    • 7.2.3. Industries and services catered
    • 7.2.4. Product benchmarking
    • 7.2.5. Strategic initiatives
  • 7.3. Abbott Laboratories
    • 7.3.1. Company overview
    • 7.3.2. Financial performance
    • 7.3.3. Industries and services catered
    • 7.3.4. Product benchmarking
    • 7.3.5. Strategic initiatives
  • 7.4. Hologic, Inc.
    • 7.4.1. Company overview
    • 7.4.2. Financial performance
    • 7.4.3. Industries and services catered
    • 7.4.4. Product benchmarking
    • 7.4.5. Strategic initiatives
  • 7.5. Thermo Fisher Scientific
    • 7.5.1. Company overview
    • 7.5.2. Financial performance
    • 7.5.3. Industries and services catered
    • 7.5.4. Product benchmarking
    • 7.5.5. Strategic initiatives
  • 7.6. Danaher Corporation
    • 7.6.1. Company overview
    • 7.6.2. Financial performance
    • 7.6.3. Industries and services catered
    • 7.6.4. Product benchmarking
    • 7.6.5. Strategic initiatives
  • 7.7. Sysmex Corporation
    • 7.7.1. Company overview
    • 7.7.2. Financial performance
    • 7.7.3. Industries and services catered
    • 7.7.4. Product benchmarking
    • 7.7.5. Strategic initiatives
  • 7.8. Trivitron Healthcare
    • 7.8.1. Company overview
    • 7.8.2. Financial performance
    • 7.8.3. Industries and services catered
    • 7.8.4. Product benchmarking
    • 7.8.5. Strategic initiatives
  • 7.9. Merck KGaA
    • 7.9.1. Company overview
    • 7.9.2. Financial performance
    • 7.9.3. Industries and services catered
    • 7.9.4. Product benchmarking
    • 7.9.5. Strategic initiatives

List of Tables

  • TABLE 1 Histology and cytologymarket estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 2 Histology and cytology market estimates and forecast by region, 2014 - 2025 (USD Million)
  • TABLE 3 Cytology market estimates and forecast by region, 2014 - 2025 (USD Million)
  • TABLE 4 Histology market estimates and forecast by region, 2014 - 2025 (USD Million)
  • TABLE 5 Histology and cytology market estimates and forecast by region, 2014 - 2025 (USD Million)
  • TABLE 6 North America histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 7 North America histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 8 U.S. histology and cytology market estimates and forecast by type of examination, (USD Million)
  • TABLE 9 Canada histology and cytology market estimates and forecast by type of examination, (USD Million)
  • TABLE 10 Europe histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 11 Europe histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 12 Germany histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 13 U.K. histology and cytology market estimates and forecast by type of examination, (USD Million)
  • TABLE 14 Asia Pacific histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 15 Asia Pacific histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 16 China histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 17 Japan histology and cytology market estimates and forecast by type of examination, (USD Million)
  • TABLE 18 Central & South America histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 19 Central & South America histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 20 Brazil histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 21 Mexico histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 22 Middle East & Africa histology and cytology market estimates and forecast by country, 2014 - 2025 (USD Million)
  • TABLE 23 Middle East & Africa histology and cytology market estimates and forecast by type of examination, 2014 - 2025 (USD Million)
  • TABLE 24 South Africa histology and cytology market estimates and forecast by type of examination, (USD Million)

List of Figures

  • FIG. 1 Market research process
  • FIG. 2 Information procurement
  • FIG. 3 Primary research pattern
  • FIG. 4 Market research approaches
  • FIG. 5 Value chain based sizing &forecasting
  • FIG. 6 QFD modeling for market share assessment
  • FIG. 7 Histology and cytology market summary 2016, (USD Million)
  • FIG. 8 Market trends & outlook
  • FIG. 9 Market segmentation& scope
  • FIG. 10 Market driver relevance analysis (Current & future impact)
  • FIG. 11 Market restraint relevance analysis (Current & future impact)
  • FIG. 12 Penetration & growth prospect mapping
  • FIG. 13 SWOT Analysis, by factor (political & legal, economic and technological)
  • FIG. 14 Porter's Five Forces analysis
  • FIG. 15 Histology and cytology competitive landscape: Market position analysis (based on tests, regional presence)
  • FIG. 16 Histology and cytology market, type of examination outlook key takeaways
  • FIG. 17 Histology and cytology: Type of examination movement analysis
  • FIG. 18 Cytology market, 2014 - 2025 (USD Million)
  • FIG. 19 Cervical cancer market, 2014 - 2025 (USD Million)
  • FIG. 20 Breast cancers Market, 2014 - 2025 (USD Million)
  • FIG. 21 Other cancers market, 2014 - 2025 (USD Million)
  • FIG. 22 Histology market, 2014 - 2024 (USD Million)
  • FIG. 23 Regional market place: Key takeaways
  • FIG. 24 Histology and cytology market: Regional movement analysis
  • FIG. 25 North America histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 26 The U.S. histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 27 Canada histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 28 Europe histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 29 The U.K. histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 30 Germany histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 31 Asia Pacific histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 32 China histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 33 Japan histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 34 Central and South America histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 35 Brazil histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 36 Mexico histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 37 MEA histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 38 South Africa histology and cytology market, 2014 - 2025 (USD Million)
  • FIG. 39 Competitive strategy adopted by leading players
Back to Top